• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Oramed Pharmaceuticals Inc

+ Add to Watchlist

ORMP:US

12.5400 USD 0.2600 2.12%

As of 17:20:00 ET on 04/16/2014.

Snapshot for Oramed Pharmaceuticals Inc (ORMP)

Open: 12.0100 Day's Range: 11.6000 - 12.6500 Volume: 98,581
Previous Close: 12.2800 52wk Range: 5.0000 - 31.7300 1-Yr Rtn: +81.48%

Stock Chart for ORMP

No chart data available.
  • ORMP:US 12.5400
  • 1D
  • 1M
  • 1Y
12.2800
Interactive ORMP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORMP

Current P/E Ratio (ttm) -
Estimated P/E(08/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5400
Est. EPS (USD) (08/2014) -0.6800
Est. PEG Ratio -
Market Cap (M USD) 124.68
Shares Outstanding (M) 9.94
30 Day Average Volume 242,195
Price/Book (mrq) 13.6432
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/17/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORMP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ORMP

Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.

Nadav KidronPresident/CEOYifat ZommerCFO/Treasurer/Secretary
Miriam KidronChief Medical & Tech OfficerJoshua Hexter "Josh"VP:Business Dev/COO
More Company Profile & Key Executives for ORMP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil